EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evaluation of a rat model for assessing interventions to salvage ischemic myocardium effects of ibuprofen and verapamil






Cardiovascular Research 19(3): 132-138

Evaluation of a rat model for assessing interventions to salvage ischemic myocardium effects of ibuprofen and verapamil

Coronary ligated rats were administered i.p. injections of 6.24, 12.52 and 25.00 mg .cntdot. kg-1 ibuprofen and 5.00 and 10.00 mg .cntdot. kg-1 verapamil 1 h before ligation, 1 h after ligation, and then every 8 h for 48 h. Ibuprofen at 50.00 mg .cntdot. kg-1 was administered 1 h before ligation, 1 h after ligation and 5 h ligation. Infarct size was determined either by weighing the stained excised infarcted area or by measuring the creatine kinase activity from the excised left ventricle. Ibuprofen and verapamil treatment resulted in less myocardial damage after 48 h than placebo treatment, but the differences were generally not statistically significant. The reduction in infarct size was greater in the ibuprofen, treated animals than in the verapamil-treated rats. There was a lower mortality with ibuprofen treatment than with verapamil or placebo. This rat model was useful as a screening tool for the initial evolution of therapeutic interventions to reduce myocardial infarct size. It requires substantially less time than large animal models and can be used to examine a variety of treatment doses. These experiments also demonstrated the importance of randomization to treatment and control groups because of the possibility of disproportionate mortality affecting infarct size.


Accession: 005395626

PMID: 3986856



Related references

Salvage of ischemic myocardium by ibuprofen during infarction in the conscious dog. American Journal of Cardiology 46(1): 74-82, 1980

Salvage of reversibly ischemic myocardium by prevention of oxygen paradox effects of calmodulin and protease inhibitions quantitative evaluation. Journal of Molecular & Cellular Cardiology 16(SUPPL 2): 43, 1984

Salvage of ischemic myocardium by azapropazone in a canine model of coronary thrombosis and reperfusion. Federation Proceedings 46(3): 412, 1987

Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog. Journal of Pharmacology and Experimental Therapeutics 248(2): 654-660, 1989

Salvage of ischemic myocardium by reperfusion in a model of minimal coronary collateral blood flow. American Heart Association Monograph (124): II-261, 1986

Salvage of reperfused ischemic myocardium by LY293435 , a thrombin inhibitor, in a non-thrombotic canine model. FASEB Journal 9(3): A623, 1995

Reperfusion injury in ischemic myocardium: effects of nifedipine and verapamil. American Journal of Cardiovascular Pathology 3(1): 61-68, 1990

Protective effects of verapamil and adenosine in ischemic and reperfused myocardium. Boei Ika Daigakko Zasshi 19(4): 258-263, 1994

Cardioprotective effects of verapamil on mitochondrial function in the ischemic myocardium. Ceskoslovenska Fysiologie 37(6): 545-548, 1988

Protective effects of isovolumetric hemodilution and verapamil solution on ischemic reperfused myocardium. Biorheology 36(1-2): 100, 1999